Our news

• Meeting point: Vein Readings. NovaMedica in active communication with neurologists at the legendary conference

  26 February 2024

  

  NovaMedica actively endorsed and participated in the 20^th Anniversary Interdisciplinary Conference with International Participation “Vein Readings”, dedicated to current issues in neurology. The conference took place on February 19-21, 2024, in Moscow. NovaMedica provided support to several interesting events held to discuss modern methods of treating migraines, headaches and sleep disorders.

• NovaMedica team wishes you a Merry Christmas and a Happy New Year!

  26 December 2023

  

  NovaMedica team wishes you a Merry Christmas and a Happy New Year! The days leading up to these magical holidays always bring us excitement and joy. This is when we say our dearest wishes, since it is at this time that we believe in miracles with all our hearts. So, make your boldest wishes and may they all come true in the new year! Let 2024 be different: sometimes lively and cheerful, sometimes calm and dreamy, but always creative and successful. We hope that it will have space for new achievements and that it delights you every minute and fills your life with warmth. May your loved ones and your family always be with you, and may your home be full of friends, love and smiles.

• Grand finale from a veritable stalwart of neuroscience

  09 November 2023

  

  A real gem of the Manage Pain Congress was the Grand Finale performed by Eduard YAKUPOV, Doctor of Medical Sciences, Professor, Head of the Professor Yakupov Neuroclinic and Education Center, which was held with the support of NovaMedica.

• Battle of pharma advocates – in search of the ideal migraine therapy

  09 November 2023

  

  An exciting discussion on the treatment of migraine and headaches in the format of a competition between advocates took place at the 14^th Manage Pain Congress as part of the panel discussion “The ideal choice of treatment for a migraine attack. Triptans or NSAIDs*. Pro & Contra”, which was held with the support of NovaMedica. The most renowned experts in this medical field took to the stage to debate on strategies for combating migraines and on which medications should be the drugs of choice. It is indicative that supporters of both sides of the expert battle named the new products of NovaMedica Relonova^® and Difendum indicated for the treatment of migraine-related headaches, as preferable.

• Expert says launch of Relonova in the Russian market has given doctors new options for treating migraines

  31 October 2023

  

  On October 26-27, 2023, the First Russian Neurological Congress, one of the largest federal events for the medical community, took place in Moscow. At the congress, a report was presented by Elena FILATOVA (Doctor of Medical Sciences), Professor of the Department of Nervous System Diseases of the Institute of Professional Education of the Sechenov First Moscow State Medical University, on “New options for migraine therapy”, in which the speaker shared information on effective relief of migraine attacks – the possibilities of NSAID therapy and the new triptan in the Russian market, Relonova^®.

• New possibilities for combination therapy of sleep disorders discussed at the symposium held with the support of NovaMedica as part of the First Russian Neurological Congress

  27 October 2023

  

  An interesting discussion of new possibilities and prospects in the treatment of insomnia took place at the symposium Combination Therapy of Sleep Disorders: Possibilities and Prospects organized with the support of NovaMedica within the framework of the First Russian Neurological Congress in Moscow. The urgent nature of this topic was evident – the hall was full! Participants – more than 100 representatives of the medical community – noted the valuable opportunity to gain fresh knowledge first-hand in a comprehensive manner from well-known specialists in somnology, neurology, psychiatry and clinical pharmacology. Among other things, NovaMedica’s new drug Levroso^® Long for the treatment of sleep disorders received high praise at the symposium.

• Experts in the treatment of headaches note the positive perception of new NovaMedica drugs by the medical community

  24 October 2023

  

  At the 15^th anniversary applied research conference New Possibilities in Diagnostics and Treatment of Headaches in St. Petersburg, leading Russian experts noted the positive perception by the medical community of NovaMedica’s new products in the field of pain therapy – Relonova^® and Difendum^®.

• “Our minds, our rights” is the slogan of World Mental Health Day 2023

  09 October 2023

  

  On October 10, World Mental Health Day is celebrated at the initiative of the World Federation for Mental Health (WFMH) and with the support of WHO. This day is an opportunity to draw additional attention to the importance and need of protecting the mental health of every person. This is also a good occasion to express gratitude to doctors – psychiatrists, psychotherapists, substance abuse specialists, gerontologists – for their hard work and effort to preserve the mental health of both each patient and our society as a whole. The search for new therapeutic solutions in the field of diseases of the central nervous system (CNS), a key link in human mental health, is a priority for NovaMedica as well.

• Photo report. Doctors and experts gathered at a conference with the support of NovaMedica to join forces in the fight against migraine

  28 September 2023

  

  On September 23, 2023, the conference titled “Diagnosis and treatment of migraine: in search of perfection!” took place in Moscow with the leading experts in the field of migraine therapy with the support of NovaMedica. The topic is important, as migraine is one of the most common diseases affecting the quality of life and work ability of many people. Therefore, despite the day of the week being Saturday, interest in the event was high. The participants – Russian doctors – listened to the leading experts and asked them questions both in the hall in Moscow and via teleconference from several Russian cities, as well as in the online broadcast on the website.

• NovaMedica leaders are in the TOP 1000 Russian managers 2023

  27 September 2023

  

  The Russian Managers Association, together with Kommersant Publishing House, annually publishes an independent rating of the country's talented leaders from among the top management of Russian companies and heads of functions. TOP 1000 Russian Managers is one of the most prestigious ratings, the results of which serve as a guide for the entire business community. Two directors of the pharmaceutical company NovaMedica are among its laureates in 2023.